1. Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease;BURKE, R.E.; FAHN, S.; MAYEUX, R.; WEINBERG, H.; LOUIS, K.; WILLNER, J.H.;Neurology (NY),1981
2. Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?;HENDERSON, V.W.; WOOTEN, G.F.;Neurology (NY),1981
3. The hypothalamus in Parkinson's disease;LANGSTON, J.W.; FORNO, L.S.;Annals of Neurology,1978
4. Syndrome malin des neuroleptiques. Action benefique du dantrolene sur l'hyperthermie et la rigidite musculaire;CHABOT, D.E.R.O.H.A.N.; P., E.L.K.H.A.R.R.A.T.; D., C.O.N.S.O.; F., B.I.S.-M.U.T.H.; CH.; GOULON, M.;La Nouvelle Presse Medicale,1982
5. Fatal hyperpyrexia after withdrawal of levodopa;SECHI, G.P.; TANDA, F.; MUTANI, R.;Neurology (NY),1984